The effect of thrombospondin-1 on breast cancer metastasis

Breast Cancer Research and Treatment

Volumn 114, Issue 1, 2009, Pages 85-96

  Yee, Karen O ^a   Connolly, Caitlin M ^a   Duquette, Mark ^a   Kazerounian, Shideh ^a   Washington, Raymond ^a   Lawler, Jack ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Metastasis; Migration; Polyomavirus middle T antigen; TGF ; Transgenic mouse

Indexed keywords

GENOMIC DNA; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VIRUS MIDDLE T ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BREAST CANCER; CANCER SIZE; CELL MIGRATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GROWTH INHIBITION; LUNG METASTASIS; MACROPHAGE; METASTASIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR VOLUME;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; THROMBOSPONDIN 1;

EID: 58849135842     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9992-6     Document Type: Article

References (66)

1. H Chen ME Herndon J Lawler 2000 The cell biology of thrombospondin-1 Matrix Biol 19 597 614
2. J Lawler 2002 Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth J Cell Mol Med 6 1 12
3. GN Naumov E Bender D Zurakowski SY Kang D Sampson E Flynn RS Watnick O Straume LA Akslen J Folkman N Almog 2006 A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype J Natl Cancer Inst 98 316 325
4. RS Watnick YN Cheng A Rangarajan TA Ince RA Weinberg 2003 Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis Cancer Cell 3 219 231
5. J Lawler WM Miao M Duquette N Bouck RT Bronson RO Hynes 2001 Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice Am J Pathol 159 1949 1956
6. OV Volpert R Pili HA Sikder T Nelius T Zaichuk C Morris CB Shiflett MK Devlin K Conant RM Alani 2002 Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1 Cancer Cell 2 473 483
7. LF Brown AJ Guidi SJ Schnitt L Van De Water ML Iruela-Arispe TK Yeo K Tognazzi HF Dvorak 1999 Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast Clin Cancer Res 5 1041 1056
8. S Schultz-Cherry J Lawler JE Murphy-Ullrich 1994 The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta J Biol Chem 269 26783 26788
9. SE Crawford V Stellmach JE Murphy-Ullrich SM Ribeiro J Lawler RO Hynes GP Boivin N Bouck 1998 Thrombospondin-1 is a major activator of TGF-beta1 in vivo Cell 93 1159 1170
10. JC Rodriguez-Manzaneque TF Lane MA Ortega RO Hynes J Lawler ML Iruela-Arispe 2001 Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor Proc Natl Acad Sci USA 98 12485 12490
11. K Gupta P Gupta R Wild S Ramakrishnan RP Hebbel 1999 Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis Angiogenesis 3 147 158
12. K Bein M Simons 2000 Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity J Biol Chem 275 32167 32173
13. OV Volpert T Zaichuk W Zhou F Reiher TA Ferguson PM Stuart M Amin NP Bouck 2002 Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor Nat Med 8 349 357
14. B Jimenez OV Volpert SE Crawford M Febbraio RL Silverstein N Bouck 2000 Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nat Med 6 41 48
15. JE Nor RS Mitra MM Sutorik DJ Mooney VP Castle PJ Polverini 2000 Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway J Vasc Res 37 209 218
16. Y Shaked F Bertolini S Man MS Rogers D Cervi T Foutz K Rawn D Voskas DJ Dumont Y Ben-David J Lawler J Henkin J Huber DJ Hicklin RJ D'Amato RS Kerbel 2005 Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis Cancer Cell 7 101 111
17. DC Rafii B Psaila J Butler Dk Jin D Lyden 2008 Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow derived cells Arterioscler Thromb Vasc Biol 28 217 222
18. S Magnetto G Bruno-Bossio C Voland J Lecerf J Lawler P Delmas R Silverstein P Clezardin 1998 CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptotaxis on immobilized thrombospondin-1 Cell Biochem Funct 16 211 221
19. DW Dawson SF Pearce R Zhong RL Silverstein WA Frazier NP Bouck 1997 CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells J Cell Biol 138 707 717
20. V Urquidi D Sloan K Kawai D Agarwal AC Woodman D Tarin S Goodison 2002 Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis Clin Cancer Res 8 61 74
21. DL Weinstat-Saslow VS Zabrenetzky K VanHoutte WA Frazier DD Roberts PS Steeg 1994 Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis Cancer Res 54 6504 6511
22. R Yabkowitz PJ Mansfield VM Dixit SJ Suchard 1993 Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains Cancer Res 53 378 387
23. JC Adams J Lawler 2004 The thrombospondins Int J Biochem Cell Biol 36 961 968
24. D Albo VL Rothman DD Roberts GP Tuszynski 2000 Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor Br J Cancer 83 298 306
25. D Albo DH Berger TN Wang X Hu V Rothman GP Tuszynski 1997 Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system Surgery 122 493 499 discussion 499-500
26. TN Wang X Qian MS Granick MP Solomon VL Rothman DH Berger GP Tuszynski 1996 Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer J Surg Res 63 39 43
27. D Albo DH Berger GP Tuszynski 1998 The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion J Surg Res 76 86 90
28. D Albo JP Arnoletti A Castiglioni MS Granick MP Solomon VL Rothman GP Tuszynski 1994 Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro Biochem Biophys Res Commun 203 857 865
29. TN Wang XH Qian MS Granick MP Solomon VL Rothman GP Tuszynski 1995 The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen Am J Surg 170 502 505
30. JP Arnoletti D Albo MS Granick MP Solomon A Castiglioni VL Rothman GP Tuszynski 1995 Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells Cancer 76 998 1005
31. CT Guy RD Cardiff WJ Muller 1992 Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease Mol Cell Biol 12 954 961
32. JE Maglione D Moghanaki LJ Young CK Manner LG Ellies SO Joseph B Nicholson RD Cardiff CL MacLeod 2001 Transgenic Polyoma middle-T mice model premalignant mammary disease Cancer Res 61 8298 8305
33. EY Lin JG Jones P Li L Zhu KD Whitney WJ Muller JW Pollard 2003 Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases Am J Pathol 163 2113 2126
34. J Lawler M Sunday V Thibert M Duquette EL George H Rayburn RO Hynes 1998 Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia J Clin Invest 101 982 992
35. WM Miao WL Seng M Duquette P Lawler C Laus J Lawler 2001 Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms Cancer Res 61 7830 7839
36. KO Yee M Streit T Hawighorst M Detmar J Lawler 2004 Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta Am J Pathol 165 541 552
37. T Inoue D Plieth CD Venkov C Xu EG Neilson 2005 Antibodies against macrophages that overlap in specificity with fibroblasts Kidney Int 67 2488 2493
38. C Lanari I Luthy CA Lamb V Fabris E Pagano LA Helguero N Sanjuan S Merani A Molinolo 2001 Five novel hormone-responsive cell lines derived frommurine mamnary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins Cancer Res 61 293 302
39. EY Lin JW Pollard 2004 Macrophages: modulators of breast cancer progression Novartis Found Symp 256 158 168 discussion 168-172, 259-169
40. EY Lin JF Li L Gnatovskiy Y Deng L Zhu DA Grzesik H Qian XN Xue JW Pollard 2006 Macrophages regulate the angiogenic switch in a mouse model of breast cancer Cancer Res 66 11238 11246
41. EY Lin JW Pollard 2007 Tumor-associated macrophages press the angiogenic switch in breast cancer Cancer Res 67 5064 5066
42. KO Yee CM Connolly M Pines J Lawler 2006 Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism Cancer Biol Ther 5 218 224
43. X Zhang J Lawler 2007 Thrombospondin-based antiangiogenic therapy Microvasc Res 74 90 99
44. JC Anderson JR Grammer W Wang LB Nabors J Henkin JE Stewart Jr CL Gladson 2007 ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis Cancer Biol Ther 6 454 462
45. JS Isenberg C Yu DD Roberts 2008 Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells Biochem Pharmacol 75 875 882
46. JG Harpel S Schultz-Cherry JE Murphy-Ullrich DB Rifkin 2001 Tamoxifen and estrogen effects on TGF-beta formation: role of thrombospondin-1, alphavbeta3, and integrin-associated protein Biochem Biophys Res Commun 284 11 14
47. SM Ribeiro M Poczatek S Schultz-Cherry M Villain JE Murphy-Ullrich 1999 The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta J Biol Chem 274 13586 13593
48. SM Ribeiro S Schultz-Cherry JE Murphy-Ullrich 1995 Heparin-binding vitronectin up-regulates latent TGF-beta production by bovine aortic endothelial cells J Cell Sci 108 Pt 4 1553 1561
49. S Schultz-Cherry H Chen DF Mosher TM Misenheimer HC Krutzsch DD Roberts JE Murphy-Ullrich 1995 Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1 J Biol Chem 270 7304 7310
50. S Schultz-Cherry S Ribeiro L Gentry JE Murphy-Ullrich 1994 Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system J Biol Chem 269 26775 26782
51. S Schultz-Cherry JE Murphy-Ullrich 1993 Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism J Cell Biol 122 923 932
52. JE Murphy-Ullrich S Schultz-Cherry M Hook 1992 Transforming growth factor-beta complexes with thrombospondin Mol Biol Cell 3 181 188
53. K Tan M Duquette JH Liu Y Dong R Zhang A Joachimiak J Lawler JH Wang 2002 Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication J Cell Biol 159 373 382
54. DW Dawson OV Volpert SF Pearce AJ Schneider RL Silverstein J Henkin NP Bouck 1999 Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat Mol Pharmacol 55 332 338
55. R Simantov RL Silverstein 2003 CD36: a critical anti-angiogenic receptor Front Biosci 8 s874 s882
56. T Nakagawa SR Martinez Y Goto K Koyanagi M Kitago T Shingai DA Elashoff X Ye FR Singer AE Giuliano DS Hoon 2007 Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes Clin Cancer Res 13 4105 4110
57. C Alix-Panabieres V Muller K Pantel 2007 Current status in human breast cancer micrometastasis Curr Opin Oncol 19 558 563
58. JE Lang CS Hall B Singh A Lucci 2007 Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application? Expert Rev Anticancer Ther 7 1463 1472
59. P Bornstein EH Sage 2002 Matricellular proteins: extracellular modulators of cell function Curr Opin Cell Biol 14 608 616
60. G Orend R Chiquet-Ehrismann 2006 Tenascin-C induced signaling in cancer Cancer Lett 244 143 163
61. AB Tuck AF Chambers AL Allan 2007 Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management J Cell Biochem 102 859 868
62. R Moura M Tjwa P Vandervoort K Cludts MF Hoylaerts 2007 Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation Arterioscler Thromb Vasc Biol 27 2163 2169
63. GP Tuszynski TB Gasic VL Rothman KA Knudsen GJ Gasic 1987 Thrombospondin, a potentiator of tumor cell metastasis Cancer Res 47 4130 4133
64. TN Wang XH Qian MS Granick MP Solomon VL Rothman DH Berger GP Tuszynski 1996 Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor Surgery 120 449 454
65. X Zhang E Galardi M Duquette M Delic J Lawler S Parangi 2005 Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model Clin Cancer Res 11 2337 2344
66. GJ Byrne KE Hayden G McDowell H Lang CC Kirwan L Tetlow S Kumar NJ Bundred 2007 Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer Int J Oncol 31 1127 1132